Skip to main content
OpenTrials

Clinical trial condition

Plaque, Amyloid

Explore clinical trials studying Plaque, Amyloid. Study availability and eligibility vary by location and protocol.

224 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Plaque, Amyloid trial results

Completed

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

NCT02752776

Conditions
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +6 more
Locations
  • Novartis Investigative Site Geel, BEL, Belgium
  • Novartis Investigative Site Bruges, Belgium
  • Novartis Investigative Site Ghent, Belgium
  • Novartis Investigative Site Seraing, Belgium
View all 215 locations
View Trial Details
Completed

A Study in Participants With Moderate to Severe Psoriasis

NCT01107457

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Haven, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
View all 34 locations
View Trial Details
Completed

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

NCT01561053

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations
  • Northern California Research Sacramento, California, United States
  • Mountain View Clinical Research, Inc Denver, Colorado, United States
  • Howard University Washington D.C., District of Columbia, United States
  • Bradenton Research Center, Inc. Bradenton, Florida, United States
View all 40 locations
View Trial Details
Completed

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

NCT02474069

Conditions
Moderate to Severe Plaque-type Psoriasis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +6 more
Locations
  • Novartis Investigative Site Bad Bentheim, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
View all 89 locations
View Trial Details
Completed

Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667

Conditions
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +5 more
Locations
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vienna, Austria
View all 200 locations
View Trial Details
Completed

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +10 more
Locations
  • Novartis Investigative Site Le Mans, Cedex 09, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Toulon, Val De Marne, France
  • Novartis Investigative Site Amiens, France
View all 17 locations
View Trial Details

Related conditions